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Background: There are 16 possible Metabolic Syndrome (MS) combinations out of 5 conditions (glucose
intolerance, low levels of high-density lipoprotein Cholesterol (HDL-C), high triglycerides, high blood pressure
and abdominal obesity), when selecting those with at least three. Studies suggest that some combinations have
different cardiovascular risk. However evaluation of all 16 combinations is complex and difficult to interpret. The
purpose of this study is to describe and explore a classification of MS groups according to their lipid alterations.
Methods: This is a cross-sectional study with data from the Mexican National Health and Nutrition Survey 2006.
Subjects (n = 5,306) were evaluated for the presence of MS; four mutually-exclusive MS groups were considered:
mixed dyslipidemia (altered triglycerides and HDL-C), hypoalphalipoproteinemia: (normal triglycerides but low
HDL-C), hypertriglyceridemia (elevated triglycerides and normal HDL-C) and without dyslipidemia (normal triglycerides
and HDL-C). A multinomial logistic regression model was fitted in order to identify characteristics that were associated
with the groups.
Results: The most frequent MS group was hypoalphalipoproteinemia in females (51.3%) and mixed dyslipidemia in
males (43.5%). The most prevalent combination of MS for both genders was low HDL-C + hypertension + abdominal
obesity (20.4% females, 19.4% males). The hypoalphalipoproteinemia group was characteristic of women and less
developed areas of the country. The group without dyslipidemia was more frequent in the highest socioeconomic
level and less prevalent in the south of the country. The mixed dyslipidemia group was characteristic of men, and the
Mexico City region.
Conclusions: A simple system to classify MS based on lipid alterations was useful to evaluate prevalences by diverse
biologic and sociodemographic characteristics. This system may allow prevention and early detection strategies with
emphasis on population-specific components and may serve as a guide for future studies on MS and cardiovascular risk.
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In recent years, Mexico has undergone the so-called nu-
tritional transition in which dietary and physical activity
patterns have changed, bringing with it a change in
chronic disease patterns and a decrease in infectious dis-
eases [1]. However, the level of this transition varies
depending on the geographical area of the country.
Mexico’s southern region is the least developed region.
It is characterized by a traditional diet and a higher* Correspondence: sbarquera@insp.mx
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article, unless otherwise stated.level of physical activity, while the northern region is
more developed and its population usually consumes
an energy dense diet rich in sugar, fat and sodium [2].
Metabolic syndrome (MS) refers to a combination of
metabolic risk factors that lead to cardiovascular events
(CVE) [3,4]. According to the most recent classification
for MS, at least three of the following altered conditions
are required in order to arrive at a diagnosis: high waist
circumference, high blood pressure, high triglycerides,
low high-density lipoprotein cholesterol (HDL-C) and
high fasting glucose [4]. These criteria allow for sixteenCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
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volve the same cardiovascular risk.
Some studies have identified combinations of compo-
nents of MS that have a higher risk of CVE, cerebrovascu-
lar events and mortality [5-9]. Additionally, it has been
shown that low HDL-C levels and high triglyceride levels
are an independent risk factor for cardiovascular disease
[10-12]. Moreover, it has been proposed to use the trigly-
ceride/HDL-C ratio as a marker of cardiovascular risk and
insulin resistance [12].
According to the 2006 Mexican National Health and
Nutrition Survey (ENSANUT from its Spanish acro-
nym), the prevalence of MS in Mexico approaches 49.8%
(47.5%-52.1%) in the adult population (≥ 20 years old)
[13]. Although 31.5% of Mexican adults have hypertri-
glyceridemia, only 3.8% of the population reported to
been previously diagnosed, thus making this one of the
main national challenges for public health [14].
This study focus on identifying and describing MS
groups based on the presence of hypertriglyceridemia
and/or hypoalphalipoproteinema since they play an im-
portant role in the development of MS, insulin resistance
and cardiovascular risk, and are generally asymptomatic.Methods
A secondary analysis was carried out on data obtained
from the ENSANUT 2006. This survey was conducted
from October 2005 to May 2006. ENSANUT 2006 is a
probabilistic, cluster-stratified survey with national, re-
gional and state representation that collected health, nu-
trition and sociodemographic information from 48,600
households. In addition, fasting venous blood samples
were obtained from a randomized subsample designed
with adequate power to detect conditions with a preva-
lence of at least 8% at the national level, by region and
urban/rural location, resulting in a total of 6,021 sub-
jects ≥20 y [15]. The sampling weights were calculated
considering the age and sex distribution of the Mexican
National population census. No statistically significant dif-
ferences were found in biological and socio-economic
characteristics between the subsample and the whole adult
ENSANUT 2006 sample [13]. The present analysis was
conducted in 2012–2013.Data collection
Trained surveyors administered a standardized question-
naire to the subjects in order to obtain personal data
such as age, level of education, socioeconomic level, al-
cohol and tobacco consumption, as well as chronic dis-
ease diagnostic and treatment information [16].
Anthropometric information was obtained using stand-
ard procedures by trained personnel. Waist circumference
was measured at the midpoint between the highest part ofthe iliac crest and the lowest part of the ribs margin of the
median axial line [15,16].
Serum glucose concentrations were measured using an
automatized glucose oxidase method, with an overall
inter-assay coefficient of variation (CV) of <5%. Serum
triglyceride concentrations were measured after lipase
hydrolysis in an automatic analyzer with a tungsten
lamp. The inter-assay CV was 5.7%. HDL-C was mea-
sured by an enzymatic colorimetric direct method after
eliminating chylomicrons, very-low-density lipoproteins
(VLDL), and low-density lipoproteins by enzymatic di-
gestion; the inter-assay CV was 5.02% [15,16].
Details on the methodology for anthropometric, clinical
and biochemical measurements, as well as the methods
used to calculate the sample, have been reported in previ-
ous publications [15,16].
The country was divided into four geographic regions
for analysis. The Northern region, includes the states of
Baja California, Baja California Sur, Coahuila, Chihuahua,
Durango, Nuevo Leon, Sonora and Tamaulipas; the
Central region, the states of Aguascalientes, Colima,
Guanajuato, Jalisco, Mexico, Michoacan, Morelos, Nayarit,
Queretaro, San Luis Potosi, Sinaloa and Zacatecas; the
Mexico City region; and the Southern region, the states
of Campeche, Chiapas, Guerrero, Hidalgo, Oaxaca, Puebla,
Quintana Roo, Tabasco, Tlaxcala, Veracruz and Yucatan.
A principal component analysis of household appli-
ances and community conditions was estimated as a
proxy for socio-economic level (SEL). The variables in-
cluded in the analysis were household characteristics
(floor and ceiling material, total number of rooms in the
household), number of persons residing in the house-
hold, possession of refrigerator, washing machine and
stove and the number of electric appliances in the
household (radio, TV, video player, telephone, and com-
puter). The main first principal component explained
40.4% of the total variance with a Kaiser-Mayer-Olkin
measure of sampling adequacy equal to 0.83. The range
of the first principal component scores was divided into
tertiles and used as a proxy for low, medium and high
SEL [16].
Diagnosis of metabolic syndrome
The diagnosis of MS was made when at least 3 compo-
nents of MS were altered according to the harmonized
criteria of the International Diabetes Federation (IDF),
World Health Organization (WHO), National Heart,
Lung and Blood Institute (NHLBI), International Ath-
erosclerosis Society and the International Association for
the Study of Obesity [4] (Table 1).
Metabolic syndrome groups
Combinations of MS were grouped in relation to the pres-
ence of hypertriglyceridemia and hypoalphalipoproteinemia
Table 1 Criteria for metabolic syndrome diagnosis
Conditions Cutoff points
Hypertension (mm Hg) or drug treatment
for hypertension control
≥130/85
Tryglicerides (mg/dL) ≥ 150






Glucose (mg/dl) or drug treatment for glucose control ≥ 100
Adapted from Alberti KGMM. et al. [4].
(Three or more conditions).
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group consisted of those with altered triglyceride and
HDL-C levels; the hypoalphalipoproteinemia group con-
sisted of those subjects with normal triglyceride levels but
low HDL-C levels; the hypertriglyceridemia group had
subjects with elevated triglyceride levels but normal HDL-
C levels; and the no dyslipidemia group were subjects with
normal triglyceride and HDL-C levels.
Statistical analysis
Exploratory analysis
For comparison between different groups, analysis of
variance was used for continuous variables and χ2 or dif-
ference between proportions tests were used for categorical
variables. The Bonferroni correction was used in multiple
comparisons [17].
Inferential statistics
In order to predict the group in which an individual be-
longs with the highest probability, an unconditional multi-
nomial logistic regression model was fitted in which the
reference MS group was the mixed dyslipidemia. The
dependent variable was the categorical variable indicating
the MS group to which the individual belonged and the
independent variables were sex, age, geographic region,
location, SEL tertile, level of education, nutritional
state and previous diagnosis of diabetes and hyperten-
sion. The Hosmer-Lemeshow test was performed to
assess the goodness of fit of the model [18].
Estimation procedures included sampling weights to
adjust for the sample complex design. Analysis was car-
ried out using the SVY module for complex samples
with the STATA version 11.1 statistical package.
Ethical considerations
Because this is a secondary study, the investigators have
no access to the subject’s personal information. Origin-
ally, for the ENSANUT 2006, the participants wereinformed about the objectives of the survey, the method-
ology used and consent to participate was obtained. This
protocol and the ENSANUT protocol was approved by
the Ethics Committee at the Mexican National Institute
of Public Health.
Results
For this study, we included cases reporting at least eight
hours of fasting at the time the blood sample was col-
lected (n = 6021). We excluded pregnant women (n = 95),
and 620 cases with missing data or samples with biological
implausible data for glucose (<30 mg/dl), HDL-C and tri-
glycerides (<10 mg/dl), waist circumference (<50 cm) or
blood pressure (systolic blood pressure < 80 mmHg or dia-
stolic blood pressure < 50 mmHg) leaving a total analytic
sample of 5,306 observations. An attrition analysis, based
on sociodemographic variables as sex, age, SEL and resi-
dence area was carried out showing no significant differ-
ences between the subjects excluded and included.
The prevalence of MS in the Mexican population was
49.9%. The most prevalent components were low HDL-
C (76.8%) and abdominal obesity (73.6%), while the least
prevalent was hypertriglyceridemia (30.9%). The preva-
lence of hypertension, abdominal obesity and high glu-
cose was not statistically different between urban and
rural areas, by geographic region, and by SEL (p >0.05)
(data not shown).
Seven percent of the subjects with elevated triglycer-
ides reported to have been previously diagnosed, while
more than 80% of subjects with elevated triglycerides
had MS. 64.4% of subjects with abdominal obesity and
56.4% of subjects with low HDL-C had MS.
Metabolic syndrome groups
Table 2 shows the prevalence of the MS groups and
combinations among them. The MS group with hypoal-
phalipoproteinemia was the most prevalent in the overall
Mexican population (46.0%), while the most frequent
combination of MS was low HDL-C + high blood pres-
sure (HBP) + abdominal obesity (AO) (20.0%). The same
MS group and combination was observed with the high-
est frequency in women as in the general population,
while the group of MS with mixed dyslipidemia was
most prevalent in men (43.5%), with the most common
combination in this group being hypertriglyceridemia
(HTG) + low HDL-C + AO. The least prevalent group
was MS without dyslipidemia (3.1).
Sociodemographic characteristics of the MS groups
The prevalence of MS was similar between men and
women. However, when it was stratified by group, the
hypoalphalipoproteinemia group was 31% more preva-
lent in women (51.5%) than men (39.2%) (p <0.05), while
Table 2 Prevalence of metabolic syndrome groups and combinations stratified by sex




altered n = 2707 n = 1716 n = 991
% 95% CI % 95% CI % 95% CI
Group 1: Mixed dyslipidemia 40.7 (37.5,44.1) 38.5 (34.5,42.6) 43.5 (38.9,48.2)
Low HDL-C + High
Triglycerides +
Hypertension 3 1.2 (0.7,2.1) 0.4 (0.1,1.2) 2.2 (1.2,4.0)
High Glucose 3 1.5 (0.9,2.5) 0.6 (0.3,1.2) 2.6 (1.4,5.0)
Abdominal Obesity 3 11.7 (9.7,14.0) 11.6 (9.3,14.4) 11.8 (8.5,16.0)
Hypertension + High Glucose 4 0.4 (0.2,0.9) 0.1 (0.0,0.3) 0.9 (0.4,1.8)
Hypertension + Abdominal Obesity 4 8.4 (6.7,10.4) 8.8 (6.5,11.7) 7.9 (5.9,10.5)
High Glucose + Abdominal Obesity 4 7.6 (5.8,10.0) 8.2 (5.7,11.7) 6.9 (4.8,9.7)
Hypertension + Abdominal Obesity +
High Glucose
5 10.0 (8.3,12.1) 8.9 (7.2,10.9) 11.4 (8.5,15.1)
Group 2: Hypoalphalipoproteinemia 46.0 (42.6,49.5) 51.6 (47.3,55.8) 39.2 (34.7,44.0)
Low HDL-C+
Hypertension + High Glucose 3 1.4 (0.9,2.1) 0.8 (0.4,2.0) 2.0 (1.3,3.2)
Hypertension + Abdominal Obesity 3 20.0 (17.6,22.6) 20.4 (17.5,23.6) 19.4 (15.8,23.7)
High Glucose + Abdominal Obesity 3 11.7 (9.9,13.8) 16.2 (13.3,19.4) 6.2 (4.4,8.5)
Hypertension + Abdominal Obesity +
High Glucose
4 13.0 (11.3,14.9) 14.1 (12.0,16.6) 11.6 (9.1,14.7)
Group 3: Hypertriglyceridemia 10.2 (8.4,12.2) 7.8 (5.9,10.2) 13.1 (10.3,16.6)
High triglycerides+
Hypertension + High Glucose 3 0.5 (0.3,1.2) 0.1 (0.0,0.8) 1.1 (0.4,2.4)
Hypertension + Abdominal Obesity 3 2.8 (2.0,3.8) 2.1 (1.2,3.4) 3.7 (2.5,5.6)
High Glucose alterada + Abdominal Obesity 3 2.9 (2.1,4.0) 3.1 (2.1,4.5) 2.8 (1.6,4.8)
Hypertension + Abdominal Obesity + High
Glucose
4 3.9 (2.9,5.2) 2.5 (1.6,3.9) 5.5 (3.7,8.1)
Group 4: Without dyslipidemia 3.1 (2.154,4.353) 2.2 (1.4,3.4) 4.1 (2.5,6.8)
Hypertension + Abdominal Obesity + High Glucose 3 3.1 (2.2,4.4) 2.2 (1.4,3.4) 4.1 (2.5,6.8)
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men (13.1%) than in women (7.8%) (p <0.05).
As age increased, the prevalence of MS also increased.
This prevalence was <30% in younger subjects, doubled in
those older than 40 y, and was >70% in subjects over 50 y.
The prevalence of the mixed dyslipidemia group was slightly
higher than 40% in subjects between 20–50 y. Nevertheless,
a decrease of 30.3% was observed in those ≥ 60 y.
The prevalence of MS was higher in urban areas than
in rural areas (51.2% versus 45.1%, p <0.05). Similar re-
sults were seen in all MS groups except for the hypoal-
phalipoproteinemia group, which showed a 27% higher
prevalence in rural than urban areas (p <0.05).
The prevalence of MS was similar among the SEL ter-
tiles. However, the hypoalphalipoproteinemia group was
22% more prevalent in the low SEL when compared to
the high SEL tertile (p <0.05) (Table 3).
The predictors associated with belonging to the
hypoalphalipoproteinemia group in the multinomial
logistic regression model were being female and living
in the northern region of the country when comparedto living in Mexico City (p <0.01). The factors that best
predicted belonging to the hypertriglyceridemia group
were being male, having over 50 y and residing in Mexico
City when compared to the northern region (p <0.01).
Finally, there was a lower probability of finding indi-
viduals without dyslipidemia in the southern region of
the country (p <0.05) (Table 4).
Discussion
This study shows different MS groups as well as the
prevalence of these groups according to sociodemo-
graphic variables. We classified four mutually exclusive
groups of MS based on the absence or presence of
changes in triglycerides and HDL-C since these factors
play an important role in the development of MS, insu-
lin resistance, and because they are major mediators in
the atherogenic process. In addition, several studies have
identified the lipid profile as an insulin resistance and
cardiovascular risk marker [11,12,19].
The prevalence of MS in our study was 49.9%, only a
0.1% point higher than the one previously reported [13].









n = 2707 n = 980 n = 1349 n= 285 n = 93
n % (95% CI) % (95% CI) % (95% CI) % (95% CI) % (95% CI)
Total n = 2707 2,707 49.9 40.7 46.0 10.2 3.1
Sex
Womena 1,716 50.4(47.5,53.3) 38.5(34.5,42.6) 51.5(47.3,55.8) 7.8(5.9,10.2) 2.2(1.4,3.4)
Men 991 49.4(45.9,52.8) 43.5(38.9,48.2) 39.2(34.7,44.0)a 13.1(10.3,16.5)a 4.1(2.5,6.8)
Age
20-29a 295 27.1(22.9,31.8)b,c,d,e 45.4(35.6,55.5) 47.0(37.6,56.6) 4.4(2.2,8.7)d,e 3.3(0.6,16.1)
30-39b 633 44.5(40.5,48.6)a,c,d,e 43.2(36.8,49.8)e 44.8(38.5,51.2) 10.6(6.8,16.0) 1.5(0.8,2.9)
40-49c 638 62.0(57.2,66.6)a,b 41.7(35.5,48.2) 48.0(41.7,54.4)d 7.7(5.6,10.6)d 2.6(1.6,4.1)
50-59d 509 70.0(64.9,74.7)a,b 44.4(38.2,50.7)e 36.1(30.6,42.1)c,e 16.2(12.1,21.3)a,c 3.3(1.9,5.6)
≥60e 632 70.3(66.2,74.0)a,b 30.3(25.4,35.7)b,d 52.9(46.6,59.1)d 11.7(8.2,16.4)a 5.1(3.1,8.2)
Area
Rurala 774 45.1(41.2,49.1) 35.5(30.2,41.1) 55.7(50.2,61.1) 6.8(4.9,9.6) 2.0(1.2,3.2)
Urban 1,933 51.2(48.4,54.0)a 42.0(38.2,45.9) 43.7(39.7,47.8)a 11.0(8.9,13.4)a 3.3(2.2,4.9)
Region
Northa 714 50.7(47.3,54.2) 35.8(30.2,41.9) 49.8(43.8,55.8)c 9.6(6.5,13.8)c 4.8(3.2,7.1)d
Centerb 937 50.2(45.6,54.8) 43.1(37.2,49.3) 44.9(39.0,50.9)c,d 8.5(6.2,11.7)c 3.5(1.8,6.5)
Mexico Cityc 97 56.4(44.9,67.2) 57.9(48.0,67.3)d 10.5(5.4,19.3)a,b,d 29.5(20.7,40.2)a,b,d 2.1(0.3,11.7)
Southd 959 47.3(44.3,50.3) 35.7(31.2,40.4)c 55.9(51.0,60.7)b,c 6.9(5.2,9.1)c 1.5(0.9,2.7)a
Socioeconomic Level
Lowa 1,056 48.5(45.1,51.9) 38.3(33.7,43.1) 51.6(46.6,56.5)c 8.1(6.0,10.7) 2.0(1.3,3.2)
Middleb 961 51.3(48.0,54.7) 42.5(37.4,47.7) 45.1(40.2,50.1) 10.5(7.9,13.9) 1.9(1.2,3.0)
Highc 682 50.3(45.5,55.2) 41.0(34.9,47.4) 42.1(36.1,48.4)a 11.5(8.2,15.9) 5.3(3.0,9.1)
Eduaction Level
Less than elementary schoola 1,739 57.4(54.7,60.1) 37.7(33.8,41.7) 49.3(45.2,53.3) 9.9(8.0,12.2) 3.2(2.3,4.4)
Elementary school or higher 965 42.9(39.5,46.4)a 44.8(39.3,50.3) 41.7(36.4,47.3) 10.5(7.8,14.1) 3.0(1.5,6.0)
Diabetes previously diagnosed 677 79.7(75.2,83.5) 35.9(30.5,41.6) 49.0(43.0,55.0) 11.1(7.8,15.4) 4.0(2.4,6.6)
Hypertension previously diagnosed 332 89.0(82.3,93.4) 38.5(30.7,46.9) 50.5(41.7,59.3) 9.1(5.6,14.4) 1.9(0.9,3.9)
Hypertriglyceridemia previously
diagnosed
175 76.3(67.2,83.4) 42.8(33.1,53.2) 38.5(28.6,49.4) 15.5(8.7,26.1) 3.2(1.1,8.7)
Body Mass Index Category (Kg/m2)
18.5 – 24.9a 348 23.8(20.2,27.9)b,c 46.0(37.5,54.8) 40.6(33.4,48.3) 10.3(6.9,15.0) 3.2(1.2,7.7)
25 – 29.9b 1,122 54.2(50.6,57.7)a,c 40.8(36.2,45.5) 45.2(40.3,50.2) 10.7(8.2,14.0) 3.3(1.7,6.2)
≥ 30c 1,203 73.9(70.7,76.9)a,b 38.4(33.6,43.4) 49.2(44.3,54.2) 9.6(7.3,12.6) 2.8(1.9,3.9)
a, b, c ,d, eP Value <0.05 for difference between proportions when comparing between categories of sociodemographic characteristics, with Bonferroni Adjustment.
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where cases with at least one missing value in any MS
component were excluded from the analytic sample.
While MS appears to be characteristic of certain popu-
lation groups such as older subjects and those living in
urban areas, a similar distribution was observed by SELtertile. When MS was stratified by group, the following
characteristics were observed:
Mixed dyslipidemia group
The principal finding in this group was the decreased
prevalence in subjects ≥60 y, which may be explained by a
Table 4 Sociodemographic predictors of metabolic syndrome groups
Mixed dyslipidemia Hypoalphalipoproteinemia Hypertrigliceridemia Without dyslipidemia
OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
Sex (women)
Men 1.0 0.69** (0.53 , 0.91) 1.71** (1.14 , 2.55) 1.61 (0.93 , 2.77)
Age (20–29 years)
30-39 years 1.0 0.99 (0.60 , 1.63) 2.71* (1.09 , 6.74) 0.39 (0.06 , 2.65)
40-49 years 1.0 0.99 (0.62 , 1.59) 1.94 (0.79 , 4.72) 0.86 (0.15 , 4.97)
50-59 years 1.0 0.70 (0.42 , 1.16) 4.31** (1.74 , 10.70) 1.05 (0.15 , 7.10)
≥ 60 years 1.0 1.51 (0.91 , 2.48) 4.36** (1.63 , 11.71) 2.47 (0.49 , 12.29)
Area (Rural)
Urban 1.0 0.83 (0.61 , 1.14) 1.07 (0.64 , 1.79) 1.11 (0.55 , 2.22)
Region (North)
Central 1.0 0.78 (0.53 , 1.13) 0.73 (0.40 , 1.34) 0.69 (0.30 , 1.59)
Federal District 1.0 0.12** (0.05 , 0.27) 1.92* (1.01 , 3.67) 0.27 (0.04 , 1.95)
South 1.0 1.07 (0.75 , 1.54) 0.79 (0.44 , 1.39) 0.43* (0.19 , 0.99)
Socioeconomic Level (Low)
Middle 1.0 0.92 (0.69 , 1.24) 1.11 (0.67 , 1.83) 0.80 (0.38 , 1.68)
High 1.0 0.99 (0.68 , 1.44) 1.19 (0.65 , 2.19) 2.29 (0.88 , 5.91)
Education Level (Less than primary)
Primary or higher 1.0 0.93 (0.68 , 1.28) 0.96 (0.61 , 1.54) 0.73 (0.39 , 1.37)
Body mass Index Category (Normal)
Overweight 1.0 1.37 (0.89 , 2.12) 1.04 (0.57 , 1.89) 1.27 (0.33 , 4.83)
Obesity 1.0 1.5 (0.97 , 2.31) 1.14 (0.62 , 2.09) 1.20 (0.35 , 4.07)
Diabetes previously diagnosed 1.0 1.17 (0.78 , 1.76) 0.71 (0.40 , 1.26) 0.47 (0.19 , 1.14)
Hypertension previously diagnosed 1.0 1.24 (0.90 , 1.70) 1.03 (0.63 , 1.69) 1.26 (0.64 , 2.50)
***p Value <0.01, Multinomial regression Model. Reference group: Mixed Dyslipidemia.
**P Value <0.05, Multinomial regression Model. Reference group: Mixed Dyslipidemia.
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HDL-C and hypertriglyceridemia. Mazza et al. followed
3,257 women for 12 years and found that those in the low-
est HDL-C quintile and the highest triglycerides quintile
had a mortality risk almost three times higher than
women in the highest HDL-C quintile or those in the low-
est triglycerides quintile [11].Hypertriglyceridemia group
This group was more prevalent in men, in the Mexico
City region and in subjects ≥50 y. It has been reported
that a high consumption of alcoholic beverages and sim-
ple carbohydrates increase the risk of hypertriglyc-
eridemia. A report of the ENSANUT 2006 revealed that
consumption of alcoholic and sugar sweetened beverages
was higher in men than in women, with the latter be-
ing the primary source of simple sugars in the Mexican
diet [20,21].
The fact that this group was more prevalent in Mexico
City may be explained by the lifestyle of its inhabitants,which include a higher consumption of industrialized
food, and lower physical activity levels compared to the
rest of the regions [22,23]. However, these results should
be interpreted with caution since the sample size in this
region was small when compared to other regions.Hypoalphalipoproteinemia group
The hypoalphalipoproteinemia group was more preva-
lent in the south region, low SEL and rural areas. High
total fat, mono and polyunsaturated fatty acids consump-
tion increases HDL-C concentrations [24,25]. Therefore,
differences in dietary patterns among regions of the coun-
try could partially explain variations in MS groups. Studies
of ENSANUT, that evaluated the distribution of fat con-
sumption by sociodemographic characteristics, found that
around 60% have a low consumption of polyunsaturated
fats, and a lower total fat and mono- and polyunsaturated
fat consumption was found in rural locations, in the
southern region of the country and in subjects in the
lowest SEL [21,26]. Another possible explanation for
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prevalence of physical activity in this population given
that physical activity has been associated with an in-
crease in lipoprotein lipase activity, which produces a
decrease in triglyceride levels [27]. According to
ENSANUT 2006, the prevalence of physical activity was
higher in these locations [22].
The hypoalphalipoproteinemia group was more preva-
lent in women when compared to men. The difference
in prevalence between men and women in the MS
groups with normal HDL-C may be explained by the dif-
ferent cutoff points for hypoalphalipoproteinemia be-
tween genders. The harmonized MS criteria and the
ADA proposed different cutoff points for HDL-C be-
tween men and women (<40 mg/dl in men; <50 mg/dl
in women) [4,28]. These differences have been proposed
because the average HDL-C levels are higher in women
than in men, and having the same cutoff point would
diagnose more men than women. Nevertheless, it does
not necessarily mean that the risk is different [29]. HDL-
C levels according to gender have been studied in other
populations; Davis et al. evaluated mean HDL-C levels
in men and women in six countries and found that
women had higher HDL-C levels on average. However,
there was great variability found among populations.
The highest difference found between men and women
(15.6 mg/dl) was reported in Canada while a smaller dif-
ference (2.3 mg/dl) was found in China [30]. Differences
between men and women Korean adults were similar
than those in the Chinese population (2.5 mg/dl) [31].
In our population, the age-adjusted difference in HDL-
C by gender was 3.2 mg/dl (38.9 mg/dl in women and
35.7 mg/dl in men), similar to that seen in the Chinese
and Korean populations. When the 40 and 50 mg/dl cut-
off points were used for men and women respectively,
the prevalence of hypoalphalipoproteinemia was 68.7%
for men and 83.6% for women, but when the 40 mg/dl
cutoff point was used for both genders, the prevalence
of hypoalphalipoproteinemia in women decreased by
27.6 percentage points and the prevalence was even
higher in men than in women (68.7% versus 56.0%). In
addition, the prevalence of MS in women decreased
from 50.4% to 42.4% and the prevalence of MS with nor-
mal HDL-C (hypertriglyceridemia and no dyslipidemia
groups) increased from 10% to 29%.
The use of different criteria for hypoalphalipoproteine-
mia by gender in the Mexican population does not ap-
pear to be completely justified given the similarity in
HDL-C levels by gender. When these criteria are ap-
plied, the prevalence of MS and its groups may be differ-
entially affected. Given that the cutoff points of 40 mg/
dl and 50 mg/dl were made based on the large HDL-C
differences found between genders in other populations,
it may be advisable to rethink these cutoff points for theMexican population as well as for other populations in
which the difference in HDL-C by gender is very small,
as seen in the Korean and Chinese populations [30,31].Group without dyslipidemia
Unlike the hypoalphalipoproteinemia group, the group
without dyslipidemia was uncommon in the south re-
gion of the country and in the low socioeconomic level
group. This may also be explained by the quality of diet
in this population [21].
One of the most interesting results found in this study
is the low level of medical diagnoses of hypertriglyc-
eridemia. Nevertheless, 80% of the subjects with elevated
triglyceride levels had MS. Thus, it may be advisable to in-
clude serum triglyceride measurements in routine medical
evaluations, as this is an area of opportunity for prevent-
ing cardiovascular events given that hypertriglyceridemia
is a modifiable risk factor.
One of the limitations of this study is that there was
not sufficient power to include more analytical variables
such as dietary and physical activity characteristics that
may contribute to explain the sociodemographic differ-
ences between the different MS groups. Given that this
is a cross-sectional analysis derived from a national sur-
vey in which additional measurements of cardiovascular
risk were not collected, it was not possible to identify
groups or combinations with a higher cardiovascular
risk.
There is no general agreement regarding an adequate
waist circumference cutoff point for the Mexican popu-
lation due to significant differences in height and body
composition compared to Caucasians and other ethnic
groups. However, the latest IDF MS definition recom-
mends a lower cutoff point for central and South American
populations [4]. Besides, a major sensitivity analysis in
Mexican population showed that the IDF cutoff point had
a better sensitivity for detection of diabetes, hypertension
and metabolic syndrome, compared with the AHA cutoff
point [32].
Other authors have described groups based on differ-
ent MS components such as abdominal obesity [33].
However the MS groups based on lipid alterations seem
to be useful because in our population 95% of the sub-
jects with MS have abdominal obesity, therefore group-
ing MS using this factor does not provide balanced groups
useful to characterizing the condition. In addition, the distri-
bution of the other components (high glucose, hypertension
and abdominal obesity) in the subjects with MS, among
area, geographic region and SEL was not significantly
different. A factor analysis of information coming from
African population showed that the strongest predic-
tors for MS were high blood pressure, triglycerides and
HDL-C, which could support our MS classification [34].
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The MS classification proposed here could be useful to
describe different characteristics of this condition. From
a public health perspective, this approach could be help-
ful to identify and to target prevention, treatment and
early detection interventions according to demographic
and biological characteristics. For example, for the popu-
lation living in the south of Mexico in rural areas and
with low SEL, an intervention could be focused on in-
creasing the consumption of mono and polyunsaturated
fatty acids while in the central region of the country and
Mexico City the promotion of physical activity could be
more important given the most prevalent groups in those
regions (hypoalphalipoproteinemia group and hypertri-
glyceridemia group respectively).
This is the first study in Mexico to describe and classify
groups of MS combinations. Subsequent analyses could
evaluate these groups to better understand the different
cardiovascular and metabolic outcomes associated.
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